Journal
CANCER COMMUNICATIONS
Volume 40, Issue 12, Pages 681-693Publisher
WILEY
DOI: 10.1002/cac2.12115
Keywords
hepatocellular carcinoma; immune subtype; molecular subtyping; multi‐ omics subtype; mutation subtype; precision medicine; proteomic subtype; transcriptome genotype
Categories
Funding
- National Science and Technology Major Project of China [2017ZX10203205]
- Science Foundation of Zhejiang province [LQ18H160006]
Ask authors/readers for more resources
Hepatocellular carcinoma (HCC) is one of the most prevalent and fatal digestive tumors. Treatment for this disease has been constraint by heterogeneity of this group of tumors, which has greatly limited the progress in personalized therapy. Although existing studies have revealed the genetic and epigenetic blueprints that drive HCCs, many of the molecular mechanisms that lead to HCCs remain elusive. Recent advances in techniques for studying functional genomics, such as genome sequencing and transcriptomic analyses, have led to the discovery of molecular mechanisms that participate in the initiation and evolution of HCC. Integrative multi-omics analyses have identified several molecular subtypes of HCC associated with specific molecular characteristics and clinical outcomes. Deciphering similar molecular features among highly heterogeneous HCC patients is a prerequisite to implementation of personalized therapeutics. This review summarizes the current research progresses in precision therapy on the backbone of molecular subtypes of HCC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available